Skip to main content

Avid Bioservices, Inc.

CDMODelisted Feb 5, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0000704562

Avid Bioservices, Inc. was delisted on Feb 5, 2025; its insiders filed their last Form 4 on Feb 7, 2025; 196 institutions reported holding it in 13F filings for Q4 2024, worth $840.8M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Avid Bioservices, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CDMO: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders169170+1
Shares64.6M64.9M+327.6K (+0.5%)
Value$1.21B$907.2M−$304.2M (−25.1%)

New holders (17)

Institutions that held Avid Bioservices, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CDMO in Q2 2023
InstitutionSharesValue% of portfolio
Rice Hall James & Associates, LLC252,723$3.53M0.20%
Balyasny Asset Management LLC192,679$2.69M0.01%
Globeflex Capital L P134,160$1.87M0.21%
B. Riley Asset Management, LLC72,981$1.02M0.37%
Boothbay Fund Management, LLC36,996$516.8K0.02%
Winton Group Ltd17,816$248.9K0.02%
Verition Fund Management LLC13,854$193.5K0.00%
Gsa Capital Partners LLP13,033$182.0K0.02%
Stifel Financial Corp10,600$148.1K0.00%
FNY Investment Advisers, LLC5,000$69.0K0.09%
Whittier Trust Co3,400$47.5K0.00%
Pinebridge Investments, L.P.2,185$30.5K0.00%
ICA Group Wealth Management, LLC2,086$29.1K0.01%
Bollard Group LLC249$3.00K0.00%
Lindbrook Capital, LLC25$3490.00%
Farther Finance Advisors, LLC15$2100.00%
Sofos Investments, Inc.14––

Sold out (16)

Institutions that held Avid Bioservices, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.